臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)

???ui.leftmenu.abouttair???
	???ui.leftmenu.explanation???

???ui.leftmenu.bartitle???
	Repositories
	Author
	Title
	Date
	???ui.leftmenu.statisticschart???
	???ui.leftmenu.realtimefacts???
	???ui.leftmenu.trend???

???index.news???
	2019臺灣學術機構典藏研討會
	機構典藏系統RC7版本已發佈

???ui.leftmenu.copyrighttitle???
	???ui.leftmenu.copyrightpublisher???
	???ui.leftmenu.copyrightconference???

???ui.leftmenu.link???
	機構典藏計畫網站
	ROAR
	OpenDOAR
	SHERPA
	OAIster
	JAIRO
	Ira
	DSPACE
	RWWR
	臺大學術典藏NTU Scholars

"gow c h"???jsp.browse.items-by-author.description???

???jsp.browse.items-by-author.back???
???jsp.browse.items-by-author.order1???	???jsp.browse.items-by-author.order2???

Showing items 51-75 of 104 (5 Page(s) Totally)
<< < 1 2 3 4 5 > >>
View [10|25|50] records per page

Institution	Date	Title	Author
臺大學術典藏	2020-08-12T08:25:21Z	A comprehensive analysis of clinical outcomes in lung cancer patients harboring a MET exon 14 skipping mutation compared to other driver mutations in an East Asian population	Gow C.-H.; Hsieh M.-S.; SHANG-GIN WU; Shih J.-Y.
臺大學術典藏	2020-08-12T06:35:52Z	Acquired gefitinib-resistant mutation of EGFR in a chemonaive lung adenocarcinoma harboring gefitinib-sensitive mutation L858R	Gow C.-H.;Shih J.-Y.;Chang Y.-L.;Chong-Jen Yu; Gow C.-H.; Shih J.-Y.; Chang Y.-L.; CHONG-JEN YU
臺大學術典藏	2020-08-12T06:35:35Z	Comparison of epidermal growth factor receptor mutations between primary and corresponding metastatic tumors in tyrosine kinase inhibitor-naive non-small-cell lung cancer	Gow C.-H.; Chang Y.-L.; Hsu Y.-C.; Tsai M.-F.; Wu C.-T.; CHONG-JEN YU; Yang C.-H.; Lee Y.-C.; Yang P.-C.; Shih J.-Y.
臺大學術典藏	2020-07-21T06:25:16Z	Oncogenic Function of a KIF5B-MET Fusion Variant in Non-Small Cell Lung Cancer	Shih J.-Y.; Gow C.-H.;Liu Y.-N.;Li H.-Y.;Hsieh M.-S.;Chang S.-H.;Luo S.-C.;Tzu-Hsiu Tsai;Chen P.-L.;Tsai M.-F.;Shih J.-Y.; Gow C.-H.; Liu Y.-N.; Li H.-Y.; Hsieh M.-S.; Chang S.-H.; Luo S.-C.; TZU-HSIU TSAI; Chen P.-L.; Tsai M.-F.
臺大學術典藏	2020-07-21T06:25:15Z	Acquired resistance to EGFR tyrosine kinase inhibitors is mediated by the reactivation of STC2/JUN/AXL signaling in lung cancer	Liu Y.-N.;Tsai M.-F.;Wu S.-G.;Chang T.-H.;Tzu-Hsiu Tsai;Gow C.-H.;Chang Y.-L.;Shih J.-Y.; Liu Y.-N.; Tsai M.-F.; Wu S.-G.; Chang T.-H.; TZU-HSIU TSAI; Gow C.-H.; Chang Y.-L.; Shih J.-Y.
臺大學術典藏	2020-07-21T06:09:11Z	Discordant HER2 Exon 20 mutation status determines a differential sensitivity to Afatinib	Liu Y.-N.; Shih J.-Y.; WEI-YU LIAO; Gow C.-H.
臺大學術典藏	2020-06-17T03:01:31Z	Upregulation of microRNA-137 expression by Slug promotes tumor invasion and metastasis of non-small cell lung cancer cells through suppression of TFAP2C	Chang T.-H.;Tsai M.-F.;Gow C.-H.;Wu S.-G.;Liu Y.-N.;Chang Y.-L.;Sung-Liang Yu;Tsai H.-C.;Lin S.-W.;Chen Y.-W.;Kuo P.-Y.;Yang P.-C.;Shih J.-Y.; Chang T.-H.; Tsai M.-F.; Gow C.-H.; Wu S.-G.; Liu Y.-N.; Chang Y.-L.; SUNG-LIANG YU; Tsai H.-C.; Lin S.-W.; Chen Y.-W.; Kuo P.-Y.; Yang P.-C.; Shih J.-Y.
臺大學術典藏	2020-05-26T09:27:27Z	Epidermal growth factor receptor mutations in needle biopsy/aspiration samples predict response to gefitinib therapy and survival of patients with advanced nonsmall cell lung cancer	Shih J.-Y;Gow C.-H;Yu C.-J;Chih-Hsin Yang;Chang Y.-L;Tsai M.-F;Hsu Y.-C;Chen K.-Y;Su W.-P;Yang P.-C.; Shih J.-Y; Gow C.-H; Yu C.-J; CHIH-HSIN YANG; Chang Y.-L; Tsai M.-F; Hsu Y.-C; Chen K.-Y; Su W.-P; Yang P.-C.
臺大學術典藏	2020-05-26T09:27:26Z	Survival outcome and predictors of gefitinib antitumor activity in East Asian chemonaive patients with advanced nonsmall cell lung cancer	Chih-Hsin Yang;Shih J.-Y;Chen K.-C;Yu C.-J;Yang T.-Y;Lin C.-P;Su W.-P;Gow C.-H;Hsu C;Chang G.-C;Yang P.-C.; CHIH-HSIN YANG; Shih J.-Y; Chen K.-C; Yu C.-J; Yang T.-Y; Lin C.-P; Su W.-P; Gow C.-H; Hsu C; Chang G.-C; Yang P.-C.
臺大學術典藏	2020-05-26T09:27:24Z	Radiotherapy in lung adenocarcinoma with brain metastases: Effects of activating epidermal growth factor receptor mutations on clinical response	Yang P.-C.;Chih-Hsin Yang;Yu C.-J;Chang Y.-C;Shih J.-Y;Kuo S.-H;Chiu Y.-H;Chang Y.-L;Chien C.-R;Gow C.-H; Gow C.-H; Chien C.-R; Chang Y.-L; Chiu Y.-H; Kuo S.-H; Shih J.-Y; Chang Y.-C; Yu C.-J; CHIH-HSIN YANG; Yang P.-C.
臺大學術典藏	2020-05-26T09:27:23Z	Lung cancer with epidermal growth factor receptor exon 20 mutations is associated with poor gefitinib treatment response	Yang P.-C.;Shin J.-Y;Yu C.-J;Chang Y.-L;Gow C.-H;Chih-Hsin Yang;Wu S.-G;Wu J.-Y; Wu J.-Y; Wu S.-G; CHIH-HSIN YANG; Gow C.-H; Chang Y.-L; Yu C.-J; Shin J.-Y; Yang P.-C.
臺大學術典藏	2020-05-26T09:27:22Z	Frequent epidermal growth factor receptor gene mutations in malignant pleural effusion of lung adenocarcinoma	Shih J.-Y; Lee Y.-C; Yang P.-C.; Yang P.-C.;Lee Y.-C;Shih J.-Y;Hsu Y.-C;Chih-Hsin Yang;Chang Y.-L;Yu C.-J;Gow C.-H;Wu S.-G; Wu S.-G; Gow C.-H; Yu C.-J; Chang Y.-L; CHIH-HSIN YANG; Hsu Y.-C
臺大學術典藏	2020-05-26T09:27:21Z	First- or second-line therapy with gefitinib produces equal survival in non-small cell lung cancer	Yang P.-C.;Shih J.-Y;Wei P.-F;Hsu Y.-C;Chang Y.-C;Gow C.-H;Chiu Y.-H;Wu S.-G;Chih-Hsin Yang;Yu C.-J;Wu J.-Y; Wu J.-Y; Yu C.-J; CHIH-HSIN YANG; Wu S.-G; Chiu Y.-H; Gow C.-H; Chang Y.-C; Hsu Y.-C; Wei P.-F; Shih J.-Y; Yang P.-C.
臺大學術典藏	2020-05-26T09:27:19Z	Comparison of epidermal growth factor receptor mutations between primary and corresponding metastatic tumors in tyrosine kinase inhibitor-naive non-small-cell lung cancer	Gow C.-H; Chang Y.-L; Hsu Y.-C; Tsai M.-F; Wu C.-T; Yu C.-J; CHIH-HSIN YANG; Lee Y.-C; Yang P.-C; Shih J.-Y.
臺大學術典藏	2020-05-25T01:32:58Z	Validation of immunohistochemistry for the detection of BRAF V600E-mutated lung adenocarcinomas	Gow C.-H.; Hsieh M.-S.; YEN-TING LIN; Liu Y.-N.; Shih J.-Y.
臺大學術典藏	2020-05-20T05:11:42Z	Validation of immunohistochemistry for the detection of BRAF V600E-mutated lung adenocarcinomas	Shih J.-Y.;Liu Y.-N.;YEN-TING LIN;Hsieh M.-S.;Gow C.-H.; Gow C.-H.; Hsieh M.-S.; YEN-TING LIN; Liu Y.-N.; Shih J.-Y.
臺大學術典藏	2020-04-10T12:51:25Z	Survival outcome and predictors of gefitinib antitumor activity in East Asian chemonaive patients with advanced nonsmall cell lung cancer	Gow C.-H.; Chiun Hsu; Chang G.-C.; Yang P.-C.; Su W.-P.; Lin C.-P.; Yang T.-Y.; Yu C.-J.; Chen K.-C.; Shih J.-Y.; Yang C.-H.; Yang C.-H.;Shih J.-Y.;Chen K.-C.;Yu C.-J.;Yang T.-Y.;Lin C.-P.;Su W.-P.;Gow C.-H.;Chiun Hsu;Chang G.-C.;Yang P.-C.
臺大學術典藏	2020-03-30T08:50:55Z	Comparable clinical outcomes in patients with HER2-mutant and EGFR-mutant lung adenocarcinomas	Gow C.-H.;Chang H.-T.;Lim C.-K.;Liu C.-Y.;Jin-Shing Chen;Shih J.-Y.; Gow C.-H.; Chang H.-T.; Lim C.-K.; Liu C.-Y.; JIN-SHING CHEN; Shih J.-Y.
臺大學術典藏	2020-03-07T06:56:57Z	Primary vascular leiomyosarcoma of the femoral vein leading to metastases of scalp and lungs (multiple letters) [4]	Gow C.H.;Liaw Y.S.;Yih-Leong Chang;Chang Y.C.;Yang R.S.; Gow C.H.; Liaw Y.S.; YIH-LEONG CHANG; Chang Y.C.; Yang R.S.
臺大學術典藏	2020-03-07T06:56:56Z	Acquired gefitinib-resistant mutation of EGFR in a chemonaive lung adenocarcinoma harboring gefitinib-sensitive mutation L858R	Gow C.-H.;Shih J.-Y.;Yih-Leong Chang;Yu C.-J.; Gow C.-H.; Shih J.-Y.; YIH-LEONG CHANG; Yu C.-J.
臺大學術典藏	2020-03-07T06:56:54Z	Epidermal growth factor receptor mutations in needle biopsy/aspiration samples predict response to gefitinib therapy and survival of patients with advanced nonsmall cell lung cancer	Shih J.-Y.;Gow C.-H.;Yu C.-J.;Yang C.-H.;Yih-Leong Chang;Tsai M.-F.;Hsu Y.-C.;Chen K.-Y.;Su W.-P.;Yang P.-C.; Shih J.-Y.; Gow C.-H.; Yu C.-J.; Yang C.-H.; YIH-LEONG CHANG; Tsai M.-F.; Hsu Y.-C.; Chen K.-Y.; Su W.-P.; Yang P.-C.
臺大學術典藏	2020-03-07T06:56:47Z	Radiotherapy in lung adenocarcinoma with brain metastases: Effects of activating epidermal growth factor receptor mutations on clinical response	Gow C.-H.;Chien C.-R.;Yih-Leong Chang;Chiu Y.-H.;Kuo S.-H.;Shih J.-Y.;Chang Y.-C.;Yu C.-J.;Yang C.-H.;Yang P.-C.; Gow C.-H.; Chien C.-R.; YIH-LEONG CHANG; Chiu Y.-H.; Kuo S.-H.; Shih J.-Y.; Chang Y.-C.; Yu C.-J.; Yang C.-H.; Yang P.-C.
臺大學術典藏	2020-03-07T06:56:45Z	Frequent epidermal growth factor receptor gene mutations in malignant pleural effusion of lung adenocarcinoma	Wu S.-G.; Gow C.-H.; Yu C.-J.; YIH-LEONG CHANG; Yang C.-H.; Hsu Y.-C.; Shih J.-Y.; Lee Y.-C.; Yang P.-C.
臺大學術典藏	2020-03-07T06:56:45Z	Lung cancer with epidermal growth factor receptor exon 20 mutations is associated with poor gefitinib treatment response	Wu J.-Y.;Wu S.-G.;Yang C.-H.;Gow C.-H.;Yih-Leong Chang;Yu C.-J.;Shin J.-Y.;Yang P.-C.; Wu J.-Y.; Wu S.-G.; Yang C.-H.; Gow C.-H.; YIH-LEONG CHANG; Yu C.-J.; Shin J.-Y.; Yang P.-C.
臺大學術典藏	2020-03-07T06:56:43Z	Comparison of epidermal growth factor receptor mutations between primary and corresponding metastatic tumors in tyrosine kinase inhibitor-naive non-small-cell lung cancer	Gow C.-H.; YIH-LEONG CHANG; Hsu Y.-C.; Tsai M.-F.; Wu C.-T.; Yu C.-J.; Yang C.-H.; Lee Y.-C.; Yang P.-C.; Shih J.-Y.

Showing items 51-75 of 104 (5 Page(s) Totally)
<< < 1 2 3 4 5 > >>
View [10|25|50] records per page

	English \| 正體中文 \| 简体中文 \| 0
	???header.visitor??? : 53123380 ???header.onlineuser??? : 746 ???header.sponsordeclaration???